Bobby Gaspar - Net Worth and Insider Trading
Bobby Gaspar Net Worth
The estimated net worth of Bobby Gaspar is at least $614,827 dollars as of 2024-05-25. Bobby Gaspar is the CEO of Orchard Therapeutics PLC and owns about 36,816 shares of Orchard Therapeutics PLC (ORTX) stock worth over $614,827. Details can be seen in Bobby Gaspar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bobby Gaspar has not made any transactions after 2022-04-01 and currently still holds the listed stock(s).
Transaction Summary of Bobby Gaspar
Bobby Gaspar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bobby Gaspar owns 1 companies in total, including Orchard Therapeutics PLC (ORTX) .
Click here to see the complete history of Bobby Gaspar’s form 4 insider trades.
Insider Ownership Summary of Bobby Gaspar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ORTX | Orchard Therapeutics PLC | 2022-04-01 | director & See Remarks |
Bobby Gaspar Latest Holdings Summary
Bobby Gaspar currently owns a total of 1 stock. Bobby Gaspar owns 36,816 shares of Orchard Therapeutics PLC (ORTX) as of April 1, 2022, with a value of $614,827.
Latest Holdings of Bobby Gaspar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORTX | Orchard Therapeutics PLC | 2022-04-01 | 36,816 | 16.70 | 614,827 |
Holding Weightings of Bobby Gaspar
Bobby Gaspar Form 4 Trading Tracker
According to the SEC Form 4 filings, Bobby Gaspar has made a total of 2 transactions in Orchard Therapeutics PLC (ORTX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Orchard Therapeutics PLC is the acquisition of 1,500 shares on April 1, 2022, which cost Bobby Gaspar around $11,100.
Insider Trading History of Bobby Gaspar
- 1
Bobby Gaspar Trading Performance
GuruFocus tracks the stock performance after each of Bobby Gaspar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bobby Gaspar is -25.97%. GuruFocus also compares Bobby Gaspar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bobby Gaspar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bobby Gaspar's insider trading performs compared to the benchmark.
Performance of Bobby Gaspar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.58 | | | | | |
| Relative Return to S&P 500(%) | -17.47 | | | | | |
Bobby Gaspar Ownership Network
Bobby Gaspar Owned Company Details
What does Orchard Therapeutics PLC do?
Who are the key executives at Orchard Therapeutics PLC?
Bobby Gaspar is the director & See Remarks of Orchard Therapeutics PLC. Other key executives at Orchard Therapeutics PLC include 10 percent owner & other: See Remark 1 Fmr Llc , 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Ra Capital Management, L.p. .
Orchard Therapeutics PLC (ORTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Orchard Therapeutics PLC (ORTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orchard Therapeutics PLC (ORTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Orchard Therapeutics PLC (ORTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Orchard Therapeutics PLC Insider Transactions
Bobby Gaspar Mailing Address
Above is the net worth, insider trading, and ownership report for Bobby Gaspar. You might contact Bobby Gaspar via mailing address: Orchard Therapeutics Plc, 108 Cannon Street, London X0 Ec4n 6eu.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
